Inhibrx Biosciences Inc (INXB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Return on Assets (%) | -1385.701 | -726.763 |
Return on Equity (%) | 3159.589 | 2029.254 |
Return on Invested Capital (%) | 2204.243 | 1414.286 |
Operating Margin (%) | -8769.734 | -9483.537 |
Net Profit Margin (%) | -8769.962 | -9483.721 |
Book Value Per Share | -2.98 | -3.254 |
Earnings Per Share | -47.071 | -63.251 |
Cash Per Share | N/A | N/A |
Working Capital Per Share | -5.922 | -7.918 |
Operating Profit Per Share | 0.537 | 0.667 |
EBIT Per Share | -47.07 | -63.249 |
EBITDA Per Share | -47.07 | -63.249 |
Free Cash Flow Per Share | -47.291 | -61.862 |
Fin d'année 31 Décembre 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Actions en circulation | 2,45M | 2,45M |
Fin d'année 31 Décembre 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|
USD (US$) | USD (US$) | ||
Actions en circulation | 2,45M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Capitalisation boursière | 38,86M |
Ratio cours/bénéfice | -0,22 |
Ratio prix/ventes | 21,26 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | -4,36 |
Rendement de dividende | - |
Actions en circulation | 2,45M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales